Nl-Fr

View abstract

TitleSafety of intra-vitreal injections : a 3-year experience
Purposeto evaluate the safety of intra-vitreal injections .
Methodsretrospective study of patients treated by a standart protocole of intra-vitreal injection. Evaluation of per and post-operative complications.
Results 1523 eyes received an intra-vitreal injection over a period of 32 months. Bevacizumab was injected in 843 eyes, ranibizumab in 402 eyes, pegaptanib in 223 eyes and triamcinolone acetonide in 55 eyes. Bulbar ecchymosis was frequent, allergic reaction to topical drops or povidone iodine was reported, reversible central artery occlusion occurred in 3 eyes (0.2 %), pseudo-uveitis in 1 eye (0.065 %), uveitis in 2 eyes (0.13 %) and endophthalmitis in 1 eye (0.065 %). No cases of vitreal hemorraghe, posterior capsule rupture, lens injury, retinal detachment or retinal tear were described.
Conclusion In our practice, complications of intra-vitreal injections are rare and often reversible. Endophthalmitis is exceptional and occurred in only 1 eye (0.065 %). Intra-vitreal injections are a safe procedure when standart protocole is used.
Author 1
Last nameGUAGNINI
InitialsAP
DepartmentCliniques Universitaires Saint-Luc, UCL
CityBruxelles
Author 2
Last nameSnyers
InitialsB
DepartmentCliniques Universitaires Saint-Luc, UCL
CityBruxelles
Author 3
Last nameKozyreff
InitialsA
DepartmentCliniques Universitaires Saint-Luc, UCL
CityBruxelles
top ^